PHinding Your Hope: PHA’s 2018 International PH Conference and Scientific Sessions
 

2018 Scientific Sessions Schedule

Thursday, June 28, 2018

4:30 p.m. - 7:30 p.m. Scientific Sessions Poster Hall

Friday, June 29, 2018

7:00 a.m. - 8:00 a.m. Scientific Sessions Continental Breakfast

8:00 a.m. - 8:15 a.m. Scientific Sessions Welcome and Introduction
Vinicio A. de Jesus Perez, Stanford University Medical Center, USA

8:15 a.m. - 8:45 a.m. Keynote Address: How Do You Envision Precision Medicine for PH?
Roham T. Zamanian, MD, FCCP, Stanford University Medical Center

Basic Science and Clinical Trials: Accelerating the Future

Moderators: Evan Brittain, MD, MSc; Elena A. Goncharova, PhD; Thenappan Thenappan, MD; Corey Ventetuolo, MD, MS


8:45 a.m. - 9:15 a.m. Novel Therapies Targeting the Right Ventricle
Harm Bogaard, MD, Vumc PH Kennsicentrum, NL

9:15 a.m. - 9:45 a.m. Novel Therapies Targeting the Pulmonary Vasculature
Marlene Rabinovitch, MD, Stanford University Medical Center, USA

9:45 a.m. - 10:15 a.m. Novel Clinical Trial Design and Endpoints
Steven M. Kawut, MD, MS, Penn Presbyterian Medical Center, USA

10:15 a.m. - 10:30 a.m. Coffee Break

Pathway to Developing Future PH Therapies: Road Work Ahead


10:30 a.m. - 11:15 a.m. Limitations and Opportunities for the Pharmaceutical Industry in Developing New PH Therapies
Ramona L. Doyle, MD, Blade Therapeutics, USA

11:15 a.m. - 12:00 p.m. What the FDA Wants for New PH Therapy Development and Approval
Norman Stockbridge, U.S. Food & Drug Administration, USA

12:00 p.m. - 12:10 p.m. Lunch Pickup

12:10 a.m. - 12:55 p.m. Academia, Industry, and Patient Advocacy Foundations Working Together to Develop New Therapeutics
Sagar Lonial, MD, Emory University School of Medicine, USA

1:00 p.m. - 2:00 p.m. PHA's International PH Conference General Opening Session

Pediatrics: Fast Lane or the Scenic Route?

Moderators: Dunbar Ivy, MD; Mary P. Mullen, MD

2:30 p.m. - 2:55 p.m. PH in the Pediatric Population: Insights from the PPHNet Registry
Steven H. Abman, MD, University of Colorado School of Medicine, USA

2:55 p.m. - 3:20 p.m. Lung Development and Origins of PH Associated with Chronic Lung Disease of Prematurity
David Frank, MD, PhD, The Children's Hospital of Philadelphia, USA

3:20 p.m. - 3:40 p.m. Congenital Heart Disease and PH: Novel Treatment Approaches
Stephanie S. Handler, MD, Children's Hospital of Wisconsin, USA

3:40 p.m. - 4:00 p.m. Imaging the Right Ventricle in Children
Uyen Truong, MD, University of Colorado Denver - Anschutz Medical Campus, USA

4:00 p.m. - 4:10 p.m. Coffee Break

Omics and Wearables in Pulmonary Hypertension: Are We There Yet?

Moderators: Tim Lahm, MD (Lead); C. Gregory Elliott, MD, FCCP, MACP; Roxane Paulin, PhD; Corey Ventetuolo, MD, MS


4:10 p.m. - 4:35 p.m. An Integrative Personal Omics Profile
Michael Snyder, PhD, Stanford University School of Medicine, USA

4:35 p.m. - 5:00 p.m. The NHLBI PVDOMICS Initiative: An Introduction
Anna R. Hemnes, MD, Vanderbilt University Medical Center, USA

5:00 p.m. - 5:25 p.m. The Role of Wearable Devices in PAH: The Case of CardioMEMS
Raymond L. Benza, MD, Allegheny General Hospital, USA

5:25 p.m. - 5:30 p.m. Closing Remarks

PH Clinical Sessions

Saturday, June 30, 2018

9:30 a.m. - 10:30 a.m. Palliative Care and Navigating Difficult Discussions in Pulmonary Hypertension
Rana A. Awdish, MD, MS, Henry Ford Health System, USA

11:00 a.m. - 12:00 p.m. Pulmonary Rehabilitation and Oxygen Therapy
Gerilynn L. Connors, BS, RRT, FAACVPR, FAARC, Inova Fairfax Hospital, USA

2:00 p.m. - 2:30 p.m. Lung Transplantation: From Listing to Management
Deborah J. Levine, MD, University Health System in San Antonio, USA
Dana McGlothlin, MD, Kaiser Permanente – California, USA
Moderators: Sangeeta M. Bhorade, MD; Oksana A. Shlobin, MD, FCCP; Zeenat Safdar, MD, MS, FCCP; Fernando Torres, MD


3:30 p.m. - 4:30 p.m. Pediatric PH Patients: New Guidelines and Differences From Adult Care
Erika S. Berman Rosenzweig, MD, Columbia Presbyterian Medical Center, USA
Dunbar Ivy, MD, Children's Hospital Colorado, USA

Sunday, July 1, 2018

8:00 a.m. - 9:00 a.m. Chronic Thromboembolic Pulmonary Hypertension: Cases, Controversies, Challenges and Conundrums
Josanna Rodriguez-Lopez, MD, Massachusetts General Hospital, USA
Timothy L. Williamson, MD, Kansas University Hospital, USA

9:30 a.m. - 10:30 a.m. PAH Therapies: Insurance, Patient Assistance Programs and New Therapies on the Horizon
Namita Sood, MD, FCCP, UT Health Science Center at Houston, USA